Oral oncology最新文献

筛选
英文 中文
Robotic parotidectomy via retroauricular incision: A safe and feasible approach for benign parotid tumors
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-24 DOI: 10.1016/j.oraloncology.2025.107253
Ping Han , Faya Liang , Ying Li, Peiliang Lin, Renhui Chen, Xijun Lin, Xiaoming Huang
{"title":"Robotic parotidectomy via retroauricular incision: A safe and feasible approach for benign parotid tumors","authors":"Ping Han , Faya Liang , Ying Li, Peiliang Lin, Renhui Chen, Xijun Lin, Xiaoming Huang","doi":"10.1016/j.oraloncology.2025.107253","DOIUrl":"10.1016/j.oraloncology.2025.107253","url":null,"abstract":"","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"164 ","pages":"Article 107253"},"PeriodicalIF":4.0,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143681452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of pembrolizumab monotherapy for advanced gingival malignant melanoma: A case report
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-22 DOI: 10.1016/j.oraloncology.2025.107267
Jie Li , Chong-tao Xu , Wei Wu
{"title":"Efficacy of pembrolizumab monotherapy for advanced gingival malignant melanoma: A case report","authors":"Jie Li ,&nbsp;Chong-tao Xu ,&nbsp;Wei Wu","doi":"10.1016/j.oraloncology.2025.107267","DOIUrl":"10.1016/j.oraloncology.2025.107267","url":null,"abstract":"<div><div>Oral malignant melanoma specifically denotes a rare subtype of melanoma originating in oral mucosa, characterized by a generally poor prognosis. Inhibitors targeting programmed cell death protein-1 or its ligand-1 (PD-1/PD-L1) have become widely accepted as primary treatments for malignant melanoma. The current report describes a unique case of advanced gingival malignant melanoma treated with pembrolizumab monotherapy in a 67-year-old Asian female. The report comprehensively evaluates the therapeutic potential of pembrolizumab, as well as its immune-related adverse events (irAEs).</div></div>","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"164 ","pages":"Article 107267"},"PeriodicalIF":4.0,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143681451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: Clinicopathological characterization and whole-exome sequencing insights
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-19 DOI: 10.1016/j.oraloncology.2025.107259
Nan Song , Xianglei He , Ting Duan , Luanxue Yu , Jiawei Ming , Jiawei Yu , Zhenying Guo
{"title":"Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: Clinicopathological characterization and whole-exome sequencing insights","authors":"Nan Song ,&nbsp;Xianglei He ,&nbsp;Ting Duan ,&nbsp;Luanxue Yu ,&nbsp;Jiawei Ming ,&nbsp;Jiawei Yu ,&nbsp;Zhenying Guo","doi":"10.1016/j.oraloncology.2025.107259","DOIUrl":"10.1016/j.oraloncology.2025.107259","url":null,"abstract":"","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"163 ","pages":"Article 107259"},"PeriodicalIF":4.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143670556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on, “Post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA”
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-17 DOI: 10.1016/j.oraloncology.2025.107257
Gnanaprakash Jeyaraj
{"title":"Commentary on, “Post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA”","authors":"Gnanaprakash Jeyaraj","doi":"10.1016/j.oraloncology.2025.107257","DOIUrl":"10.1016/j.oraloncology.2025.107257","url":null,"abstract":"","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"163 ","pages":"Article 107257"},"PeriodicalIF":4.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143642417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-driven histopathologic insights in HPV-positive head and neck squamous cell carcinomas
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-17 DOI: 10.1016/j.oraloncology.2025.107261
Carlos M. Ardila , Pradeep Kumar Yadalam
{"title":"AI-driven histopathologic insights in HPV-positive head and neck squamous cell carcinomas","authors":"Carlos M. Ardila ,&nbsp;Pradeep Kumar Yadalam","doi":"10.1016/j.oraloncology.2025.107261","DOIUrl":"10.1016/j.oraloncology.2025.107261","url":null,"abstract":"","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"163 ","pages":"Article 107261"},"PeriodicalIF":4.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143642418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on, “Thyroid volumes after intensity-modulated radiotherapy as predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study”
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-17 DOI: 10.1016/j.oraloncology.2025.107256
Gnanaprakash Jeyaraj
{"title":"Commentary on, “Thyroid volumes after intensity-modulated radiotherapy as predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study”","authors":"Gnanaprakash Jeyaraj","doi":"10.1016/j.oraloncology.2025.107256","DOIUrl":"10.1016/j.oraloncology.2025.107256","url":null,"abstract":"","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"163 ","pages":"Article 107256"},"PeriodicalIF":4.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143631924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to Editor on, “Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)”
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-17 DOI: 10.1016/j.oraloncology.2025.107255
Gnanaprakash Jeyaraj
{"title":"Letter to Editor on, “Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)”","authors":"Gnanaprakash Jeyaraj","doi":"10.1016/j.oraloncology.2025.107255","DOIUrl":"10.1016/j.oraloncology.2025.107255","url":null,"abstract":"","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"163 ","pages":"Article 107255"},"PeriodicalIF":4.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143631925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral HPV incidence and risk factors for acquisition
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-17 DOI: 10.1016/j.oraloncology.2025.107249
Gypsyamber DSouza , Sakshi Tewari , Tanya Troy , Paige Bleyer , Mabel Korley , Jennafer Kwait , Ken Ho , Maura Gillison , Dorothy Wiley , Jason Lazar , Kathleen M. Weber , Howard Strickler , Cecile D Lahiri , Frank Palella , Linda Struijk , Carole Fakhry
{"title":"Oral HPV incidence and risk factors for acquisition","authors":"Gypsyamber DSouza ,&nbsp;Sakshi Tewari ,&nbsp;Tanya Troy ,&nbsp;Paige Bleyer ,&nbsp;Mabel Korley ,&nbsp;Jennafer Kwait ,&nbsp;Ken Ho ,&nbsp;Maura Gillison ,&nbsp;Dorothy Wiley ,&nbsp;Jason Lazar ,&nbsp;Kathleen M. Weber ,&nbsp;Howard Strickler ,&nbsp;Cecile D Lahiri ,&nbsp;Frank Palella ,&nbsp;Linda Struijk ,&nbsp;Carole Fakhry","doi":"10.1016/j.oraloncology.2025.107249","DOIUrl":"10.1016/j.oraloncology.2025.107249","url":null,"abstract":"<div><h3>Background</h3><div>We evaluated incidence of oral HPV infection, which precedes HPV-related oropharynx cancer.</div></div><div><h3>Methods</h3><div>In this prospective multicenter cohort of participants with HIV and demographically similar participants without HIV, oral rinse and gargle samples were collected every 6–12 months and tested for 35 HPV types (anyHPV), 13 of which were oncogenic (oncHPV). Kaplan Meier and Cox regression were used for incidence curves and clustered risk factor hazard ratios. Logistic regression was used to determine relative odds of same infection at next visit.</div></div><div><h3>Results</h3><div>The 1587 participants had a median follow-up of 3.67 years, 422 had 708 incident type-specific oral HPV detected. The most common oncHPV was HPV16 [incidence rate = 7.8 per 1000 person-years (95 %CI 5.8–10.6)]. At 5 years, the cumulative incidence of anyHPV, oncHPV and HPV16 was 34.9 % (95 %CI = 31.9 %, 38.3 %), 17.1% (95 %CI = 14.8 %, 19.8 %) and 4.0 % (95 %CI = 2.9, 5.6 %), respectively. Risk of incident oral HPV infection was independently associated with a higher number of oral sex partners, current smoking, younger age, prevalent oral anyHPV, living with HIV and lower CD4 counts. Prevalent oncHPV at baseline had greater odds of being re-detected at subsequent visits than an incident oncHPV detected for the first-time at a later visit. Detection of oral HPV type at one visit was associated with highly elevated odds of detecting that same type-specific infection at the next visit (OR &gt; 100).</div></div><div><h3>Conclusion</h3><div>Cumulative incidence of oral HPV is increased among PLWH and with prevalent oral HPV, represents a mix of new and intermittently detected infections, and is higher among those with repeated detection of oral HPV.</div></div>","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"163 ","pages":"Article 107249"},"PeriodicalIF":4.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143642416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-year follow-up of a rare primary branchial cleft carcinoma: Case analysis and management insights
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-13 DOI: 10.1016/j.oraloncology.2025.107215
Jiayu Shen , Xin Wei , Zhiyan Wu , Xi Li , Sichen Han , Xinliang Duan , Yao Yuan , Peng Liu , Zilin Wang
{"title":"Two-year follow-up of a rare primary branchial cleft carcinoma: Case analysis and management insights","authors":"Jiayu Shen ,&nbsp;Xin Wei ,&nbsp;Zhiyan Wu ,&nbsp;Xi Li ,&nbsp;Sichen Han ,&nbsp;Xinliang Duan ,&nbsp;Yao Yuan ,&nbsp;Peng Liu ,&nbsp;Zilin Wang","doi":"10.1016/j.oraloncology.2025.107215","DOIUrl":"10.1016/j.oraloncology.2025.107215","url":null,"abstract":"<div><div>Branchial cleft cysts are congenital anomalies of development, with the second branchial cleft cyst being the most common clinically. In extremely rare cases, branchial cleft cysts can undergo malignant transformation. Herein, we present a rare case of a 65-year-old male patient who had a painless neck mass on the left side for 6 months. Routine postoperative histopathological examination of the resected mass revealed branchial cleft carcinoma. We excluded the possibility of systemic metastasis through PET-CT and subsequently performed radical neck dissection. Routine follow-up revealed no recurrence after surgery. A PubMed search of the literature over the past 10 years yielded only 11 articles related to branchial cleft carcinoma. We hope this case will remind clinicians of the insidious nature of branchial cleft carcinoma and the importance of routine histopathological examination of seemingly benign surgical lesions.</div></div>","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"163 ","pages":"Article 107215"},"PeriodicalIF":4.0,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143621119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in unmet needs after treatment for head and neck cancers – A prospective longitudinal cohort study
IF 4 2区 医学
Oral oncology Pub Date : 2025-03-12 DOI: 10.1016/j.oraloncology.2025.107250
John Mohan Mathew , Ionut Busca , Zeynep Baskurt , Meredith Giuliani , Naa Kwarley Quartey , Jennifer Jones , Maureen McQuestion , Janet Papadakos , John Waldron , Jessica Weiss , Jolie Ringash
{"title":"Changes in unmet needs after treatment for head and neck cancers – A prospective longitudinal cohort study","authors":"John Mohan Mathew ,&nbsp;Ionut Busca ,&nbsp;Zeynep Baskurt ,&nbsp;Meredith Giuliani ,&nbsp;Naa Kwarley Quartey ,&nbsp;Jennifer Jones ,&nbsp;Maureen McQuestion ,&nbsp;Janet Papadakos ,&nbsp;John Waldron ,&nbsp;Jessica Weiss ,&nbsp;Jolie Ringash","doi":"10.1016/j.oraloncology.2025.107250","DOIUrl":"10.1016/j.oraloncology.2025.107250","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to assess changes in unmet needs among patients with head and neck cancer (HNC) from pre-treatment to two years post-treatment and identify factors associated with higher levels of unmet needs.</div></div><div><h3>Materials &amp; Methods</h3><div>Patients treated for HNC at Princess Margaret Cancer Centre between June 2016 and February 2019 were recruited. Participants completed the Cancer Survivors’ Unmet Needs Measure Questionnaire (CaSUN), the Functional Assessment of Cancer Therapy − Head and Neck (FACT-HN) questionnaire, and the EuroQol EQ-5D-5L utility and Visual Analog Scale (EQ-5D-5L and VAS) pre-treatment and at 3, 6, 12, and 24-months post-treatment.</div></div><div><h3>Results</h3><div>Among 332 eligible patients approached, 197 were included. Significant reductions in number of unmet needs were observed between baseline and all follow-ups: 48 % fall at 3 months (p &lt; 0.001), 39 % at 6 (p = 0.001), 54 % at 12 (p &lt; 0.001), and 59 % at 24 months (p &lt; 0.001). Higher education (p = 0.018, RR 1.88 [95 % CI 1.1–3.1]) and lower baseline FACT-HN &amp; EQ-5D-5L VAS scores (p &lt; 0.001, RR 0.98 [95 % CI 0.96–0.99] &amp; p = 0.02, RR 0.99 [95 % CI 0.97–1 respectively]) were associated with higher unmet needs pre-treatment. Younger age (p = 0.041, RR 0.95 [95 %C I 0.9–1]) and lower baseline FACT-HN scores (p = 0.028, RR 0.97 [95 % CI 0.95–1]) were associated with higher unmet needs at 24 months.</div></div><div><h3>Conclusions</h3><div>Patients with HNC experience unmet needs, but the number declines from pre-treatment to two years post-treatment. Younger age, higher educational level, lower baseline FACT HN and EQ-5D-5L scores were associated with higher levels of unmet needs at various follow-up stages.</div></div>","PeriodicalId":19716,"journal":{"name":"Oral oncology","volume":"163 ","pages":"Article 107250"},"PeriodicalIF":4.0,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143610697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信